Speech-Language Pathologists in Charleston, SC Accepting Medicare

207 Speech-Language Pathologists found. Showing 121 - 140

Mrs. Bonnie Podraza, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1941 Savage Rd, Suite 400c, Charleston, SC 29407 Phone: 843-571-2700    Fax: 843-571-2124

Leah Hunt, M.S., C.C.C-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1407 Ashley River Rd, Charleston, SC 29407 Phone: 843-769-0663    Fax: 843-769-0665

Mrs. Cheryl Martschink Leonard, M.S.P. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2982 Winners Cir, Charleston, SC 29414 Phone: 843-571-3949    Fax: 843-571-3949

Ms. Cathryn Moss Austelle, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 243 Marsh Oaks Dr, Charleston, SC 29407 Phone: 843-568-6580

Mrs. Kelly Mccabe Vaughn, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2130 Pinehurst Ave, Charleston, SC 29414 Phone: 843-763-1538

Dr. Julie Marie Baker, PHD, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 895 Island Park Drive, Suite 201, Charleston, SC 29492 Phone: 843-603-4567    Fax: 843-405-1321

Tessa Simpson Gonyea, MSP, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2837 Rutherford Way, Charleston, SC 29414 Phone: 843-276-2885

Charleston St Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1563 Sam Rittenberg Blvd, Charleston, SC 29407 Phone: 774-721-6252

Jennifer B. Evans, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 109 Bee St, Charleston, SC 29401 Phone: 843-577-5011

Bonnie Bianco Martin-harris, PHD Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414

Mrs. Laura Laird Harris, M.S., CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 28 Lindendale Ave, Charleston, SC 29407 Phone: 843-209-8582

Mrs. Jennifer Tortora Tate, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 169 Ashley Ave, Msc 335, Charleston, SC 29425 Phone: 843-876-7200

Erin Elizabeth Riley Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1170 Folly Rd, Charleston, SC 29412 Phone: 843-633-3266

Ms. Ervina Delores Armstrong, CCC-SLP,L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1941 Savage Rd, Suite 400c, Charleston, SC 29407 Phone: 843-571-2700

Mr. Preston C. Hadden, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 208 Rutledge Ave, Apt. B, Charleston, SC 29403 Phone: 843-876-7200    Fax: 843-727-6401

Mrs. Luci Elsey, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 75 Calhoun St, Charleston, SC 29401 Phone: 843-937-6514    Fax: 843-937-6593

Beyond Spoken Words, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 562 Saville Row, Charleston, SC 29414 Phone: 843-822-2518

Easy Talk Pediatrics, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1643b Savannah Hwy # 202, Charleston, SC 29407 Phone: 843-580-8729    Fax: 907-308-6754

Aimee Nix Osti, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2230 Ashley Crossing Dr, Charleston, SC 29414 Phone: 843-766-5228

Ms. Tina Deluca, M.A., CCC-SLP, M.ED. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1407 Joy Ave, Charleston, SC 29407 Phone: 843-766-6753    Fax: 843-766-1430

News Archive

NPL CaviMeter fine-tunes equipment to produce right quantity and distribution of cleaning action

Ultrasonic Cleaning Systems are widely used in healthcare applications during the sterilization of surgical instruments, and in many manufacturing and process industries. They work by passing a high frequency sound wave through a liquid detergent to create thousands of small bubbles. The sound waves then makes the bubbles implode with such force, that the impacts remove contaminant particles from submerged materials.The current NHS-recommended technique to measure the performance of ultrasonic cleaning systems uses aluminium foil, which is eroded and punctured by the imploding bubbles. This is an unreliable process to apply and can contaminate the vessel cleaning fluid, adding unnecessary costs.

VTT develops innovative magnetometer for applications such as medical imaging

VTT Technical Research Centre of Finland has developed an innovative magnetometer that can replace conventional technology in applications such as neuroimaging, mineral exploration and molecular diagnostics. Its manufacturing costs are between 70 and 80 per cent lower than those of traditional technology, and the device is not as sensitive to external magnetic fields as its predecessors. The design of the magnetometer also makes it easier to integrate into measuring systems.

ESC publishes new guidelines on pericardial diseases

New ESC Guidelines on pericardial diseases are published today. Until now there was insufficient evidence for strong recommendations in this group of conditions which can severely restrict quality of life.

BMSN and ENTB collaborate with Therinjectto to develop a new immuno-therapeutic cancer vaccine

Bio-Matrix Scientific Group, Inc. and Its majority owned subsidiary Entest BioMedical Inc. announced today they have finalized a definitive agreement with Therinject LLC for the development of a new immuno-therapeutic cancer vaccine. Therinject LLC is engaged in the development of cancer treatments utilizing immunology based approaches.

Biogen and Eisai present detailed results from phase 1b study of aducanumab at CTAD meeting

Biogen and Eisai Co., Ltd. announced that Biogen presented results at the Clinical Trials on Alzheimer's Disease meeting, in Barcelona, Spain, from the recent 36- and 48-month analyses of the ongoing long-term extension of the Phase 1b study of aducanumab, an investigational treatment for mild cognitive impairment due to Alzheimer's disease and mild AD.

Read more Medical News

› Verified 2 days ago

• 1
• 2
• 3
• 4
• 5
• 6
• 7(current)
• 8
• 9
• 10
• 11